BEAM
Beam TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BEAM fundamentals
Beam Therapeutics (BEAM) released its earnings on Aug 5, 2025: revenue was 8.47M (YoY -28.05%), missed estimates; EPS was -1 (YoY +9.91%), beat estimates.
Revenue / YoY
8.47M
-28.05%
EPS / YoY
-1
+9.91%
Report date
Aug 5, 2025
Earnings Call
7:00 AM on Aug 5, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
BEAM has released its 2025 Q3 earnings report, with revenue of 9.70M, reflecting a YoY change of -32.03%, and net profit of -112.73M, showing a YoY change of -16.61%. The Sankey diagram below clearly presents BEAM's revenue sources and cost distribution.
Key Indicators
Beam Therapeutics (BEAM) key financial stats and ratios, covering profitability, financial health, and leverage.
Beam Therapeutics (BEAM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Beam Therapeutics (BEAM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Beam Therapeutics (BEAM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Beam Therapeutics (BEAM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Beam Therapeutics (BEAM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Beam Therapeutics do and what are its main business segments?What is Beam Therapeutics's gross profit margin?What is Beam Therapeutics's latest dividend and current dividend yield?Did Beam Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Beam Therapeutics next quarter?What were the key takeaways from Beam Therapeutics's earnings call?What factors drove the changes in Beam Therapeutics's revenue and profit?What guidance did Beam Therapeutics's management provide for the next earnings period?
